Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections

JP Horcajada, M Montero, A Oliver, L Sorlí… - Clinical microbiology …, 2019 - Am Soc Microbiol
In recent years, the worldwide spread of the so-called high-risk clones of multidrug-resistant
or extensively drug-resistant (MDR/XDR) Pseudomonas aeruginosa has become a public …

Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant/extensively drug-resistant/pandrug-resistant bacteria

M Bassetti, E Righi, A Vena, E Graziano… - Current opinion in …, 2018 - journals.lww.com
The exponential increase of antimicrobial resistance among virulent pathogens currently
represents one of the main challenges for clinicians in the intensive care unit. Knowledge of …

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the …

A Torres, MS Niederman, J Chastre… - European …, 2017 - Eur Respiratory Soc
The most recent European guidelines and task force reports on hospital-acquired
pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 …

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia

A Torres, MS Niederman, J Chastre, S Ewig… - ERJ open …, 2018 - Eur Respiratory Soc
The most recent European guidelines and task force reports on hospital-acquired
pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 …

Resistência bacteriana a antibióticos na Unidade de Terapia Intensiva: revisão integrativa

TS Rodrigues, AMR dos Santos, PC Lima… - Revista Prevenção de …, 2018 - revistas.ufpi.br
Objetivo: identificar a partir da literatura as principais bactérias resistentes à antibióticos em
pacientes internados nas Unidades de Terapia Intensiva. Método: Revisão integrativa da …

Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive …

J Inchai, C Liwsrisakun, T Theerakittikul… - Journal of Infection and …, 2015 - Elsevier
Ventilator-associated pneumonia (VAP) caused by Acinetobacter baumannii remains a
significant cause of morbidity and mortality. Increasing antimicrobial resistance influences …

[HTML][HTML] The effectiveness of a bundle in the prevention of ventilator-associated pneumonia

CR Ferreira, DF de Souza, TM Cunha… - Brazilian Journal of …, 2016 - SciELO Brasil
Objectives The aim of this study was to evaluate the impact of a bundle called FAST HUG in
ventilator-associated pneumonia, weigh the healthcare costs of ventilator-associated …

Management of ventilator-associated pneumonia: guidelines

ML Metersky, AC Kalil - Clinics in chest medicine, 2018 - chestmed.theclinics.com
Ventilator-associated pneumonia (VAP) remains a common problem among patients who
require invasive mechanical ventilation in acute care hospitals. Despite widespread …

Effectiveness of interventions targeting antibiotic use in long-term aged care facilities: a systematic review and meta-analysis

MZ Raban, C Gasparini, L Li, MT Baysari… - BMJ open, 2020 - bmjopen.bmj.com
Objectives There are high levels of inappropriate antibiotic use in long-term care facilities
(LTCFs). Our objective was to examine evidence of the effectiveness of interventions …

Empiric Treatment in HAP/VAP:“Don't You Want to Take a Leap of Faith?”

K Chaïbi, G Péan de Ponfilly, L Dortet, JR Zahar… - Antibiotics, 2022 - mdpi.com
Ventilator-associated pneumonia is a frequent cause of ICU-acquired infections. These
infections are associated with high morbidity and mortality. The increase in antibiotic …